ClinicalTrials.gov record
Completed Not applicable Interventional Results available

HARMONEE - Japan-USA Harmonized Assessment by Randomized, Multi-Center Study of OrbusNEich's Combo StEnt

ClinicalTrials.gov ID: NCT02073565

Public ClinicalTrials.gov record NCT02073565. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 11:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Japan-USA Harmonized Assessment by Randomized, Multi-Center Study of OrbusNEich's Combo StEnt (Japan-USA HARMONEE): Assessment of a Novel DES Platform For Percutaneous Coronary Revascularization in Patients With Ischemic Coronary Disease and NSTEMI Acute Coronary Syndrome

Study identification

NCT ID
NCT02073565
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
OrbusNeich
Industry
Enrollment
572 participants

Conditions and interventions

Interventions

  • Everolimus Eluting Stent (EES) Device
  • OrbusNeich Combo stent™ Device

Device

Eligibility (public fields only)

Age range
20 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2014
Primary completion
Jul 13, 2017
Completion
Nov 30, 2021
Last update posted
May 12, 2022

2014 – 2021

United States locations

U.S. sites
17
U.S. states
12
U.S. cities
17
Facility City State ZIP Site status
MedStar Clinical Research Center Washington D.C. District of Columbia 20010
Atlantic Clinical Research Collaborative-Cardiology Lake Worth Florida 33462
University of Miami Miami Florida 33136
Tallahassee Research Institute Tallahassee Florida 32308
Emory University Hospital Midtown Atlanta Georgia 30308
North Georgia Heart Foundation Gainesville Georgia 30501
Maine Medical Center Portland Maine 04102
Washington Adventist Hospital Takoma Park Maryland 20912
Lahey Clinic Burlington Massachusetts 01805
North Mississippi Medical Center Tupelo Mississippi 38801
Mount Sinai Medical Center New York New York 10029
University of Rochester Medical Center-Strong Memorial Hospital Rochester New York 14642
Duke University Medical Center Durham North Carolina 27705
Wake Forest Baptist Medical Center Winston-Salem North Carolina 27157
The Ohio State University Medical Center Columbus Ohio 43210
Lehigh Valley Hospital Allentown Pennsylvania 18103
Vanderbilt University Medical Center Nashville Tennessee 37232

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 33 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02073565, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 12, 2022 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02073565 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →